Author
The University of Texas MD Anderson Cancer CenterORCID 0000-0002-1821-6243Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Bingnan Zhang, Lingzhi Hong, Kaiwen Wang…·Lauren A. Byers
This study shows DLL3 expression level predicts response and long-term survival in SCLC patients treated with tarlatamab.
Catherine Allison Stewart, Kavya Ramkumar, Runsheng Wang…·Carl Michael Gay
This study identifies YAP1-positive cells in relapsed SCLC that exhibit drug tolerance and transition from SCLC to LCNEC-like features, losing some targets but gaining others.
Mukulika Bose, Cole Ruoff, Shafqat Ehsan…·Loukia Georgiou Karacosta
This study uses CyTOF to profile circulating tumor cells in SCLC patients, identifying subtype-specific markers and treatment response correlations.
Catherine Allison Stewart, Lixia Diao, Yuanxin Xi…·Carl Michael Gay